Structure (Darifenacin Structure)
Darifenacin Tablet, Extended Release
Product Images NDC 33342-277
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Darifenacin (NDC 33342-277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Darifenacin Tab 15mg 30s Container
Each extended-release tablet contains 15 mg of darifenacin hydrobromide. Darifenacin is used for the treatment of urinary incontinence. The usual dosage is one tablet daily. The tablets should be stored at a temperature between 20-25°C (68-77°F) and protected from light. This drug should be kept out of reach of children. The product is manufactured by Macleods Pharmaceuticals Ltd. for Macleods Pharma USA, Inc. and comes in a package of 30 tablets. Further information can be found in the enclosed information leaflet with the drug product.*
Darifenacin Tab 15mg 90s Container
This is a description of a medication called Darifenacin that comes in the form of extended-release tablets. The box contains 90 tablets, and each tablet contains 17.846 mg of darifenacin hydrobromide which provides less than 15 mg of darifenacin. The recommended dosage is one tablet daily, and the medication should be stored between 20 to 25°C (68 to 77°F) with permitted excursions of 15 to 30°C (59 to 86°F). The manufacturer is Macleods Pharma USA, Inc. and it is manufactured by Macleods Pharmaceuticals Ltd. The code number is HP/152/07. A patient information leaflet should be included with the medication.*
Darifenacin Tab 7 5mg 30s Container
This is a medication information leaflet for Darifenacin extended-release tablets containing 8.923mg of darifenacin hydrobromide to provide 7.5mg of darifenacin. The usual recommended dosage is one tablet per day. The tablets are stored at 20-25°C. The leaflet includes the drug's code and manufacturing information.*
Darifenacin Tab 7 5mg 90s Container
This is a drug product named "Darifenacin" manufactured by Macleods Pharma USA containing tablets of 7.5mg of Darifenacin hydrobromide. Each extended-release tablet contains 8.923 mg of Darifenacin. The usual dosage is one tablet daily, and it should be stored at 20° to 25°C (68° to 77°F). The drug product should be protected from light and kept out of the reach of children. There is also a note for pharmacists to dispense the patient information leaflet with the product. The NDC number for this drug is 33342-276-10. OPZ AREA is mentioned as 40 X 20.5mm. The drug product is manufactured for Macleods Pharma USA, Inc. The manufacturing company is Macleods Pharmaceuticals Ltd. in Baddi, Himachal Pradesh, INDIA.*
Figure-1 (Darifenacin Tab Figure 1)
Figure-2a (Darifenacin Tab Figure 2a)
Figure-2b (Darifenacin Tab Figure 2b)
Figure-2c (Darifenacin Tab Figure 2c)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
